Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial

NCT ID: NCT06016244

Last Updated: 2024-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

560 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-04

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to find out at which lower limit for saturation (amount of oxygen in the blood) we can best give extra oxygen to children that have been admitted for shortness of breath. We hope to accomplish a shorter period of illness for these children and that they can be discharged home earlier. Participants will receive supplemental oxygen if their blood oxygen levels are below 88% or below 92%. After admission, (parents of) participating children will fill out questionnaires. We will compare the two groups on their hospitalization duration and recovery.

In other words, is it better to maintain a lower limit of 88% saturation or a lower limit of 92% in children admitted for shortness of breath?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis Lower Respiratory Tract Infection Bronchial Hyperreactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial, parallel group, block randomized and stratified by age and centre.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

88% oxygen saturation threshold

Patients in this arm will receive supplemental oxygen when SpO2 falls below 88% or when other clinical symptoms indicate a need for supplemental oxygen.

Group Type EXPERIMENTAL

Oxygen saturation threshold

Intervention Type OTHER

Oxygen saturation threshold on which supplemental oxygen is decided

92% oxygen saturation threshold

Patients in this arm will receive supplemental oxygen when SpO2 falls below 92% or when other clinical symptoms indicate a need for supplemental oxygen.

Group Type ACTIVE_COMPARATOR

Oxygen saturation threshold

Intervention Type OTHER

Oxygen saturation threshold on which supplemental oxygen is decided

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen saturation threshold

Oxygen saturation threshold on which supplemental oxygen is decided

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6 weeks to 12 years of age (corrected age for children with gestational age \< 37 weeks)
* hospitalized with respiratory distress due to bronchiolitis, viral wheeze or lower respiratory tract infection, as diagnosed by the treating physician. Viral wheeze can only be diagnosed below the age of 6 years.
* requiring supplemental oxygen as per usual care (SpO2 \<92% or for treating symptoms of respiratory distress as determined by the treating physician

As respiratory distress in children with an asthma attack is mainly driven by hypoxia, they are at risk of undertreatment in the acute phase of the attack. Therefore, children aged 6-12 years of age with an asthma attack are excluded from this study.

Exclusion Criteria

* children with, except for the studied diseases, pre-existing cardiopulmonary, neurological or hematological conditions (e.g. congenital thoracic malformation, airway malacia, post infectious bronchiolitis obliterans, childhood interstitial lung disease. primary immune deficiency)
* children born \<32 weeks gestational age
* children already included in other studies, which potentially interfere with this study
* children (of parents) without a stable internet connection needed for answering questionnaires
* children previously included in the current study
* considering questionnaires are only available in Dutch and English, children (of parents) with different languages will be excluded.
Minimum Eligible Age

6 Weeks

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Spaarne Gasthuis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Annmeie LM Boehmer, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Spaarne Gasthuis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spaarne Gasthuis

Haarlem, North Holland, Netherlands

Site Status RECRUITING

Canisius Wilhelmina Ziekenhuis

Arnhem, , Netherlands

Site Status RECRUITING

Rijnstate Ziekenhuis

Arnhem, , Netherlands

Site Status RECRUITING

Amphia Ziekenhuis

Breda, , Netherlands

Site Status RECRUITING

Martini Ziekenhuis

Groningen, , Netherlands

Site Status RECRUITING

Tergooi Ziekenhuis

Hilversum, , Netherlands

Site Status RECRUITING

St Antonius Ziekenhuis

Nieuwegein, , Netherlands

Site Status RECRUITING

Franciscus Gasthuis en Vlietland

Rotterdam, , Netherlands

Site Status RECRUITING

Isala Klinieken

Zwolle, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sam Louman, MD

Role: CONTACT

+3123-2241645

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Annemie LM Boehmer, MD, PhD

Role: primary

+31232240070

Sam Louman, MD

Role: backup

+31232241645

Marianne L Brouwer

Role: primary

+31243658146

Mirjam Scheffer

Role: primary

+31880057782

Anja Vaessen-Verberne

Role: primary

+31765951012

Arvid Kamps

Role: primary

+31505245245

Caroline Kosterink-Brackel

Role: primary

+31887531160

Walter Balemans

Role: primary

+31883206300

Ismé de Kleer

Role: primary

+31104616225

Jolita Bekhof

Role: primary

+31886245050

References

Explore related publications, articles, or registry entries linked to this study.

Louman S, van Stralen KJ, Koppelman G, Vaessen-Verberne A, Bekhof J, Bosmans J, Brackel C, Kamps AWA, de Kleer I, Balemans W, Scheffer M, Brouwer M, van den Beukel M, Andrinopoulou ER, Pijnenburg MWH, Boehmer ALM. Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: protocol for a randomised controlled trial (OxyKids study). BMJ Open. 2024 Dec 22;14(12):e087891. doi: 10.1136/bmjopen-2024-087891.

Reference Type DERIVED
PMID: 39806594 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-504817-56

Identifier Type: OTHER

Identifier Source: secondary_id

2022.0100

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Home Oxygen Therapy in Bronchiolitis
NCT01216553 UNKNOWN PHASE4